Clinical Trial Design & Development of Highly Targeted Agents in the Molecular Era episode artwork

EPISODE · Oct 14, 2014 · 24 MIN

Clinical Trial Design & Development of Highly Targeted Agents in the Molecular Era

from GRACEcast · host cancerGRACE Meetings

Acquired Resistance Forum Video #5: Dr. Gideon Blumenthal of the US Food and Drug Administration (FDA) discussed the FDA process for approving targeted therapies.

Episode metadata supplied by the publisher feed · Published Oct 14, 2014

Embed this episode

NOW PLAYING

Clinical Trial Design & Development of Highly Targeted Agents in the Molecular Era

0:00 24:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 24 minutes long.

When was this GRACEcast episode published?

This episode was published on October 14, 2014.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!